Association between Obesity and Heart Failure and Related Atrial Fibrillation: Patient-Level Data Comparisons of Two

Young Shin Lee1, Pil-Sung Yang2, Eunsun Jang1

  • 1Division of Cardiology, Department of Internal Medicine, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea.

Yonsei Medical Journal
|December 28, 2023
PubMed

Insights

Obesity increases heart failure (HF) and atrial fibrillation (AF) risk in both Korean and UK adults. The UK, with higher obesity rates, showed a greater incidence of HF and HF-related AF compared to Korea.

Area of Science:

  • Cardiology
  • Epidemiology
  • Public Health

Background:

  • Heart failure (HF) and atrial fibrillation (AF) frequently coexist, impacting a significant portion of patients with either condition.
  • Understanding the influence of obesity on the relationship between HF and AF is crucial for targeted interventions.

Purpose of the Study:

  • To evaluate differences in the obesity-mediated association between heart failure and heart failure-related atrial fibrillation among Asian (Korean) and European (UK) populations.
  • To compare the incidence and risk of HF and HF-related AF based on body mass index (BMI) across these distinct ethnic groups.

Main Methods:

  • Utilized large-scale cohort data from the Korean National Health Insurance Service-Health Screening (K-NHIS-HealS) and the UK Biobank.
  • Included 394,801 Korean adults and 476,883 UK adults, aged 40-70 years.
  • Assessed the incidence and risk of HF and HF-related AF in relation to body mass index (BMI).

Main Results:

  • The UK cohort exhibited a significantly higher proportion of obese individuals (24.2%) compared to the Korean cohort (2.7%).
  • Obese individuals in the UK showed higher incidence rates of HF and HF-related AF than their Korean counterparts.
  • Obesity was associated with a 1.82-fold risk of HF in Koreans and a 2.00-fold risk in UK adults, with a significant interaction effect (p<0.001).
  • A 5-unit increase in BMI correlated with a 44% higher risk of HF-related AF in the UK, but not significantly in Korea.

Conclusions:

  • Obesity is a significant risk factor for both heart failure and heart failure-related atrial fibrillation in both Korean and UK populations.
  • The higher prevalence of obesity in the UK likely contributes to the observed greater incidence of HF and HF-related AF in this population.
  • Findings highlight ethnic and regional differences in the impact of obesity on cardiovascular health outcomes.
Abstract

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
433
Heart Failure Drugs: &#946;-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
341
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
388
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K